Site icon Global New Light Of Myanmar

Myanmar receives 30,000 Remdesivir drugs used in COVID-19 treatment from NSIC

KAT 00251 NS

The MoHS Union Minister is receiving Remdesivir for the treatment of COVID-19 from the donor National Strategic Investment Corporation Co. Ltd (NSIC) at Nay Pyi Taw Airport on 20 July 2021.

KAT 00111 NS

A Tatmadaw aircraft landed at Nay Pyi Taw Airport, carrying 30,000 Remdesivir drugs donated by the National Strategic Investment Corporation Co. Ltd (NSIC) to the State Administration Council from Hyderabad, India, yesterday evening.
Union Minister for Health and Sports Dr Thet Khaing Win received the donated drugs from the General Manager of NSIC at the airport.
The Remdesivir drugs are used for emergency treatment of COVID-19. It is the most effective medicine to reduce the death toll from the highly contagious COVID-19 virus worldwide. It was developed by Gileat Sciences Inc. in the United States of America and is FDA-approved in the US and Europe.In addition, Hetero Labs Limited from India has purchased a production licence from Gileat Sciences Inc, to manufacture and distribute Remdesivir in developing countries. NSIC ordered 30,000 drugs worth 3 billion kyats from India and donated them to the people of Myanmar through the State Administration Council.—MNA

Exit mobile version